AAAAAA

   
Results: 1-14 |
Results: 14
Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials
Authors: Crino, L Cappuzzo, F
Citation: L. Crino et F. Cappuzzo, Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials, ANTI-CANC D, 12, 2001, pp. S9-S13
Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer
Authors: Crino, L Calandri, C Maestri, A Marrocolo, F
Citation: L. Crino et al., Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer, ONCOLOGY-NY, 15(3), 2001, pp. 40-42
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer
Authors: Conte, P Salvadori, B Donati, S Gennari, A Cetto, GL Molino, A Crino, L Mazzoni, F Galligioni, E Mansutti, M
Citation: P. Conte et al., The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer, ONCOLOGY-NY, 15(2), 2001, pp. 41-43
Toxicity in small cell lung cancer (SCLC) patients submitted to twice-daily or once-daily thoracic radiotherapy (TRT) and concomitant chemotherapy (CT) long-term results
Authors: Maranzano, E Piro, F Meacci, L Bracarda, S De Angelis, V Crino, L De Marinis, F Minciarelli, M Tonato, M Latini, P
Citation: E. Maranzano et al., Toxicity in small cell lung cancer (SCLC) patients submitted to twice-daily or once-daily thoracic radiotherapy (TRT) and concomitant chemotherapy (CT) long-term results, TUMORI, 87(4), 2001, pp. S122-S123
Gemcitabine in advanced pancreatic cancer - A phase II trial
Authors: Crino, L Mosconi, AM Calandri, C Corgna, E Porrozzi, S Chiara, S Nobili, MT Tonato, M
Citation: L. Crino et al., Gemcitabine in advanced pancreatic cancer - A phase II trial, AM J CL ONC, 24(3), 2001, pp. 296-298
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer
Authors: Novello, S Galli, L Antonuzzo, A Crino, L Pozzi, E Selvaggi, G Ricci, S Marrocolo, F Darwish, S Sorbolini, S Tonato, M Scagliotti, GV
Citation: S. Novello et al., Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 261-269
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial
Authors: Rinaldi, M Crino, L Scagliotti, GV Mosconi, AM De Marinis, F Gridelli, C Selvaggi, G Della Giulia, M Darwish, S Porrozzi, S Novello, S Cipri, A Bartolucci, R Calandri, C Tonato, M
Citation: M. Rinaldi et al., A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial, ANN ONCOL, 11(10), 2000, pp. 1295-1300
The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer
Authors: Shepherd, FA Abratt, R Crino, L Green, M Sandler, A Steward, W Iglesias, J Anglin, G
Citation: Fa. Shepherd et al., The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 117-125
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial
Authors: von der Maase, H Andersen, L Crino, L Weinknecht, S Dogliotti, L
Citation: H. Von Der Maase et al., Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial, ANN ONCOL, 10(12), 1999, pp. 1461-1465
Quality-of-life improvement in patients receiving paclitaxel/platinum regimens
Authors: Crino, L Tonato, M
Citation: L. Crino et M. Tonato, Quality-of-life improvement in patients receiving paclitaxel/platinum regimens, ONCOLOGY-NY, 13(9), 1999, pp. 45-47
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
Authors: Crino, L Mosconi, AM Scagliotti, G Selvaggi, G Novello, S Rinaldi, M Della Giulia, M Gridelli, C Rossi, A Calandri, C De Marinis, F Noseda, M Tonato, M
Citation: L. Crino et al., Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial, J CL ONCOL, 17(7), 1999, pp. 2081-2085
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project
Authors: Crino, L Scagliotti, GV Ricci, S De Marinis, F Rinaldi, M Gridelli, C Ceribelli, A Bianco, R Marangolo, M Di Costanzo, F Sassi, M Barni, S Ravaioli, A Adamo, V Portalone, L Cruciani, G Masotti, A Ferrara, G Gozzelino, F Tonato, M
Citation: L. Crino et al., Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project, J CL ONCOL, 17(11), 1999, pp. 3522-3530
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer
Authors: Scagliotti, GV Crino, L Pozzi, E Corgna, E Selvaggi, G Novello, S Salsano, G Gentile, A Palladino, M Marracolo, F Tonato, M
Citation: Gv. Scagliotti et al., Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer, LUNG CANC, 25(1), 1999, pp. 39-46
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): A phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
Authors: Boni, C Savoldi, L Bisagni, G Ceci, G Crino, L De Lisi, V Di Costanzo, F Lasagni, L Manenti, AL Moretti, G Rondini, E Sassi, M Zadro, A
Citation: C. Boni et al., Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): A phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC), EUR J CANC, 34(12), 1998, pp. 1974-1976
Risultati: 1-14 |